Elephas Biosciences Corporation (Elephas), a private company that has developed the elivetm ex vivo tumor profiling platform, announced a scientific collaboration with Mithrl, an AI company focused on ...
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions, announces the U.S. launch of the ...
Palisade Bio (PALI) fell for the second consecutive session on Tuesday after initial data from an early-stage trial for its lead asset PALI-2108 in fibrostenotic Crohn’s disease (FSCD), a severe form ...
Two years of silage studies demonstrate increased tons, additional milk per acre and synthetic nitrogen replacement without sacrificing forage quality MINNEAPOLIS, March 31, 2026--(BUSINESS ...
Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...
Human reports fill the gaps that telematics can’t during disasters. Here’s how fleets can use structured input (not social ...
Shares of Cogent Biosciences (COGT) climbed ~120% in the premarket on Monday after the company disclosed encouraging late-stage trial data for its lead asset, bezuclastinib, against a form of ...
BioWorld tracked 209 clinical trial readouts across phases I through III in March 2026, up from 152 in February and 144 in January. Among late-stage programs, 26 phase III trials reported positive ...
Total med-tech financings reached $8.81 billion in the first quarter (Q1) 2026, a 6% decline from $9.33 billion in Q1 2025 but well above the post-downturn lows of recent years. The 2026 total exceeds ...
The Model 422 electro-eluter is an electroelution cell for preparative recovery of biomolecules from agarose and acrylamide gels. The eluter combines with the tank and lid of the Mini Trans-Blot® cell ...
UniPOC™ Software is an open data-management solution that seamlessly connects and manages the largest ecosystems of point-of-care devices. It is the only POC system with an automated operator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results